CONJUGATE COMPRISING A CELL-PENETRATING PEPTIDE AND COMPOSITIONS COMPRISING SAME

(19)

(11)

EP 2 873 678 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	17.07.2024 Bulletin 2024/29

(45)	Mention of the grant of the patent:
	26.06.2024 Bulletin 2024/26

(21)	Application number: 13816880.2

(22)	Date of filing: 11.07.2013

(51)

International Patent Classification (IPC):

A61K 47/64^(2017.01)
A61K 49/04^(2006.01)
C07K 7/08^(2006.01)
A61K 31/711^(2006.01)
A61P 1/16^(2006.01)
A61P 35/02^(2006.01)
A61P 37/02^(2006.01)

A61K 49/00^(2006.01)
A61K 49/14^(2006.01)
A61K 38/00^(2006.01)
A61K 31/713^(2006.01)
A61P 35/00^(2006.01)
A61P 37/00^(2006.01)
A61P 43/00^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	C07K 7/08; A61K 38/00; A61K 49/0047; A61K 47/64; A61K 31/711; A61K 31/713; A61K 49/0056; A61K 49/14; A61P 1/16; A61P 35/00; A61P 35/02; A61P 37/00; A61P 37/02; A61P 43/00

(86)	International application number:
	PCT/KR2013/006218

(87)	International publication number:
	WO 2014/010971 (16.01.2014 Gazette 2014/03)

(54)	CONJUGATE COMPRISING A CELL-PENETRATING PEPTIDE AND COMPOSITIONS COMPRISING SAME KONJUGAT ENTHALTEND EIN ZELLPENETRIERENDES PEPTID UND ZUSAMMENSETZUNGEN DAVON CONJUGUÉ COMPRENANT UNE PEPTIDE DE PÉNÉTRATION CELLULAIRE, ET COMPOSITION LE COMPRENANT

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

11.07.2012 KR 20120075444
19.09.2012 KR 20120104173
28.09.2012 KR 20120109207
18.02.2013 KR 20130017046
19.04.2013 KR 20130043635

(43)	Date of publication of application:
	20.05.2015 Bulletin 2015/21

(73)	Proprietor: Gemvax & Kael Co., Ltd.
	Daejeon 34036 (KR)

(72)	Inventor:
	KIM, Sang Jae Seoul 135-947 (KR)

(74)	Representative: Inspicos P/S
	Agern Allé 24 2970 Hørsholm 2970 Hørsholm (DK)

(56)

References cited: :

EP-A1- 0 990 701
WO-A1-00/02581
KR-A- 20070 083 218
KR-A- 20110 130 943
US-A1- 2011 318 380
US-B1- 7 078 491

EP-A1- 2 615 105
WO-A1-2012/033272
KR-A- 20100 085 527
KR-A- 20120 026 408
US-A1- 2012 065 124

LEE SEOUNG-AE ET AL: "Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine", BIOMATERIALS, vol. 34, no. 30, 1 July 2013 (2013-07-01), pages 7495 - 7505, XP028679351, ISSN: 0142-9612, DOI: 10.1016/J.BIOMATERIALS.2013.06.015

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).